Quest works on blood tests for leukaemia and lymphoma
This article was originally published in Clinica
Executive Summary
US diagnostics provider Quest Diagnostics is developing blood tests for monitoring leukaemia and lymphoma that could provide a less invasive alternative to bone marrow biopsies, which are currently used to manage the diseases.